Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
XXX - Escherichia coli Nissle 1917 / E. coli Nissle 1917 (EcN) & Crohn’s disease (CD)
The application of Escherichia coli Nissle 1917 / E. coli Nissle 1917 (EcN) was found to reduce the risk of relapse when compared to a placebo. Furthermore, this probiotic showed a steroid-sparing effect by reducing the necessity for glucocorticoids (corticosteroids) during the maintenance period. However, additional data is required to confirm the benefits of the E. coli strain Nissle 1917 as a novel therapy for maintaining remission in colonic Crohn's disease (1)
(1) Malchow 1997 J Clin Gastroenterol. 25(…